Skyrizi emerges as a vital treatment for autoimmune conditions like psoriasis and Crohn’s disease, offering relief through targeted immune system modulation. This article delves into the intricacies of Skyrizi treatment, from preparation and administration to managing side effects and navigating insurance options, empowering patients with the knowledge to make informed healthcare decisions.
Understanding Skyrizi Treatment
Skyrizi, a brand of risankizumab, is a prescription medication used to treat several autoimmune conditions, including moderate to severe plaque psoriasis, active psoriatic arthritis, moderate to severe Crohn’s disease, and moderate to severe ulcerative colitis. It works by reducing inflammation and slowing down an overactive immune system, which is crucial for managing these conditions (source). Skyrizi is administered via injection, either by a healthcare provider or self-administered at home after proper training. Understanding the specific conditions Skyrizi is approved to treat is essential for patients considering this therapy (source).
Preparing for Skyrizi Treatment
Before starting Skyrizi treatment, patients must obtain a prescription from their healthcare provider and coordinate with a specialty pharmacy for insurance validation and payment. The medication can be delivered to the patient’s home or doctor’s office, and it is crucial to keep Skyrizi refrigerated if delivered to the home (source). Patients should also inform their healthcare team about any existing conditions such as hepatic disease, immune system problems, infections, recent or upcoming vaccinations, and any allergies. This information is vital for assessing the suitability and safety of the treatment (source).
Managing Skyrizi Treatment
Skyrizi treatment involves a specific dosing regimen, including an induction phase with three intravenous infusions followed by a maintenance phase with subcutaneous doses every two months. Patients should be informed about the administration methods and receive appropriate training to maintain therapeutic response and manage their treatment effectively (source). The Complete App is a valuable tool for managing Skyrizi treatment, allowing users to log treatments, set reminders, access savings cards and rebate forms, and track symptoms to share with healthcare providers (source).
Safety and Side Effects
Important safety information includes the risk of serious allergic reactions and infections. Patients should be screened for infections and tuberculosis before starting treatment and monitored for liver problems during treatment (source). Common side effects of Skyrizi vary by condition but may include upper respiratory infections, headaches, joint pain, and injection site reactions. Patients should follow their healthcare provider’s instructions for use and report any side effects to the FDA (source).
Insurance and Financial Assistance
Understanding insurance coverage is crucial for patients starting Skyrizi treatment. AbbVie provides resources to help navigate insurance options, including assistance from Insurance Specialists for those with commercial insurance, Medicare, Medicaid, or no insurance. The Skyrizi Complete Savings Card offers eligible, commercially insured patients the opportunity to pay as little as $0 per dose, with additional prescription rebates available. However, this program is not available to those with government-funded insurance (source).
Why You Should Learn More About Skyrizi Treatment Today
Skyrizi offers a promising treatment option for individuals with autoimmune conditions such as psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. Understanding the treatment process, including preparation, administration, and potential side effects, is essential for patients considering Skyrizi. Additionally, navigating insurance options and financial assistance programs can significantly impact the accessibility and affordability of this medication. By staying informed and working closely with healthcare providers, patients can make educated decisions about their treatment plans and improve their quality of life.